Home » Topics » Regulatory

Regulatory
RSS

Eli Lilly and Boehringer Ingelheim's insulin glargine receives tentative approval from the FDA

Aug. 19, 2014

FDA approves Belsomra for insomnia

Aug. 14, 2014

FDA approves oritavancin for acute bacterial skin and skin structure infections

Aug. 7, 2014

Octapharma's Nuwiq receives E.U. approval for hemophilia A

Aug. 6, 2014

Conditional marketing authorization in E.U. for Translarna in Duchenne muscular dystrophy

Aug. 6, 2014

Plegridy approved in the E.U. for multiple sclerosis

July 24, 2014

FDA approves Zydelig for three B-cell blood cancers

July 24, 2014

FDA approves Ryanodex for treatment of malignant hyperthermia

July 24, 2014

FDA approves Kerydin for onychomycosis

July 9, 2014

Japan approves first all-oral interferon- and ribavirin-free HCV treatment

July 8, 2014

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...